Insys files for bankruptcy after $225M settlement

Opioids

Opioid maker Insys Therapeutics has filed for bankruptcy after agreeing to a $225 million global resolution to settle investigations concerning deceptive marketing and distribution of the drug Subsys.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.